Aflb.ob Teva And Depo Stock Updates - Pennytobuck.com

A5 Laboratories Inc., AFLB.ob

A5 Laboratories Inc., AFLB.ob

A5 Laboratories Inc. (OTC:AFLB) is pleased to provide an update on the company's business development activities for the month of July.

On July 5, 2010 ALFB.ob closed the acquisition of the Contract Research Organization (CRO) and laboratory assets as well as intellectual property relating to a method for the production of interferon products. Subsequently, the company entered into agreements with two CRO customers to provide a comprehensive range of services.

Most recently A5 Labs submitted a provisional patent application to protect its technology for the production of interferon-based products.

For the source of this full article click here or goto http://finance.yahoo.com/news/A5-Laboratories-Inc-iw-1544981675.html?x=0&.v=1

Teva Receives European Commission Approval for ratiopharm Acquisition

Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) announced that they received approval from the European Commission to proceed with its acquisition of ratiopharm. In connection with this approval and following the Commission's review of this transaction, Teva made certain limited commitments, which are anticipated to have only a marginal effect on the combined companies' activities. Teva now plans to close the transaction in the near future.

For the source of this full article click here or goto http://finance.yahoo.com/news/Teva-Receives-European-bw-2358203873.html?x=0&.v=2

Depomed Receives Confirmation from Pfizer That No Infringement Suit to be Filed on DM-1796 NDA

Depomed, Inc. (Nasdaq:DEPO) announced that pursuant to the Hatch-Waxman Act, the 45-day period for filing a patent infringement suit under the Act, and thus initiating a 30-month stay on the FDA's ability to approve the DM-1796 NDA, has expired. Depomed has confirmed with Pfizer Inc. that no suit under the Act has been filed. DM-1796 is an extended release, once-daily tablet formulation of gabapentin for post-herpetic neuralgia developed by Depomed.

For the source of this full article click here or goto http://finance.yahoo.com/news/Depomed-Receives-Confirmation-pz-225779512.html?x=0&.v=1

For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations.The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings, Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings, Inc. (CRWE.OB) has received eight thousand dollars in cash from a third party (Winning Media) for (one) day of advertising for A5 Laboratories Inc. (AFLB.OB)

by: Bill Pennyman

POST COMMENT

Fill In The Gaps With These 3 Steps And Save $1,000 Every Year Led Projector Lamp- The Most Demanding Gadgets Problems Arising After The Total Hip And Total Knee Replacement Surgeries How To Get Clean And Clear Skin Leslie Leland Announces Fundraising Event For Former Atlanta Governor, Roy 2010 Choose Your Metal Stamping Dies And Tooling Parts Supplier Carefully Some Basics To Invest In Asx Stock Exchange When To Sell Penny Stocks Certificate? Contributions And Limits For Your Superannuation Fund All About Toefl, Gre And Gmat How To Manage Your Own Superannuation Fund How To Set Up Your Smsf Fund A Look At The Magic Bullet Blender And Whether It Is Right For You